Hostname: page-component-6898cfcb55-cbk24 Total loading time: 0 Render date: 2026-11-11T20:16:17.491Z Has data issue: false hasContentIssue false

Acquisition Rates and Risk Factors for Carbapenem-Resistant Acinetobacter baumannii in an Emergency ICU: A Case-Control Study

Published online by Cambridge University Press:  23 June 2026

Woojung Kim
Affiliation:
Seoul National University Hospital
Mimi Lee
Affiliation:
Seoul National University Hospital, Seoul, Republic of Korea
Bomin Jeon
Affiliation:
College of Nursing and Research Institute of Nursing Science, Seoul National University
Pyoeng Gyun Choe
Affiliation:
Seoul National University Hospital
Sun Ju Chang
Affiliation:
Seoul National University

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) is a critical multidrug-resistant pathogen. The Emergency Intensive Care Unit (EICU) is particularly vulnerable to transmission due to the high-pressure environment and need for immediate clinical decisions, often made with incomplete microbiological data. While patient-related factors are traditionally prioritized, the relative contribution of invasive procedures and environmental colonization pressure in this specialized setting remains under-quantified. This study aimed to identify the determinants of CRAB acquisition through a comprehensive, hierarchical analysis of patient, treatment, and environmental factors. Methods: A retrospective case–control study was conducted at a tertiary hospital from April 2020 to December 2023. Monthly indicators of CRAB acquisition were examined in relation to environmental characteristics using Spearman correlation. A four-block multivariable hierarchical logistic regression analysis, consisting of patient demographics, clinical characteristics, treatment factors, and environmental characteristics, was performed (48 cases, 144 controls) to identify independent risk factors for CRAB acquisition and to evaluate the model’s explanatory power. Result: During the study period, the monthly CRAB acquisition rate showed a median of 1.69 (range, 0.00–14.59) per 1,000 patient-days. This rate correlated positively with colonization pressure (daily mean number of CRAB-positive inpatients; r = .399, p = .007). Although hand hygiene compliance was high (median 93.8%; range 70.0–100.0%), it showed no correlation with CRAB acquisition rate (p = .753). In the hierarchical analysis, the model’s explanatory power improved significantly as treatment and environmental blocks were added (Nagelkerke R from .043 to .609). In the final model, carbapenem use was the strongest independent predictor (OR 8.58; 95% CI, 2.62–28.09; p p = .004), enteral nutrition (OR 6.36; p = .002), and mechanical ventilation (OR 4.79; p = .037). Colonization pressure also remained a significant independent risk factor (OR 3.56; p Conclusion: CRAB acquisition in the EICU is primarily driven by carbapenem-associated selection pressure, invasive procedures involving fluid exposure, and colonization pressure. Notably, the lack of correlation between high hand hygiene compliance and acquisition rates suggests that individual-level efforts alone are insufficient to mitigate risk in high-pressure environments. Consequently, effective prevention requires a paradigm shift from individual compliance toward organizational strategies. This includes strengthening treatment-related infection prevention bundles for high-risk invasive procedures and implementing dynamic environmental controls based on real-time colonization pressure.

Information

Type
MDR GNR
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America